Home › Drug Resistant Epilepsy › NCT05928598
Goals for Epilepsy Clinic Visits Trial
Drug-Resistant Epilepsy (DRE) Goals for Epilepsy Clinical Visits mHealth Epilepsy Visit Planner Trial
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria - Patient Participants: * Adults with drug-resistant epilepsy * Participants receiving care through the Epilepsy clinics at the University of Michigan Exclusion Criteria - Patient Participants: * \<18 years old * Non-English speaking * Do not clearly have drug-resistant epilepsy * Moderate-to-severe cognitive impairment that precludes study questionnaire completion Inclusion Criteria - Provider Participants: -University of Michigan epilepsy providers Exclusion Criteria - Provider Participants: -Not University of Michigan epilepsy providers
About the study
The purpose of this project is to conduct a trial to assess whether patients that receive a tablet-based waiting room priority communication tool (the "Epilepsy Visit Planner") have improved outcomes compared to patients that do not receive the tool.
The project's hypotheses are:
* Patients that receive the Epilepsy Visit Planner will have improved patient-provider communication compared to the non-planner group. * Patients that receive the Epilepsy Visit Planner will have improved quality of life scores. * The Epilepsy Visit Planner will score highly on process measures of feasibility and acceptability, demonstrating suitability for future larger scale study.
Additionally, there is a related survey project that is not part of the clinical trial and will not be included in this registration information.
What is being tested
- Survey questionnaires (behavioral)
- Epilepsy Visit Planner (behavioral)
- Questionnaires for Providers (behavioral)
Sponsor: University of Michigan · Participants: 152 · Started: Sep 27, 2023
Contact the study team
- Queen Bolden · Phone: 734-615-5495
Official record on ClinicalTrials.gov — NCT05928598
Locations in the U.S.
| Michigan | University of Michigan, Ann Arbor |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.